Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54768087)
Watch
English
Market spiral pricing of cancer drugs.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
title
Market spiral pricing of cancer drugs.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
author
Hagop Kantarjian
series ordinal
2
object named as
Hagop Kantarjian
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
author name string
Donald W Light
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
language of work or name
English
0 references
publication date
3 September 2013
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
volume
119
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
issue
22
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
page(s)
3900-3902
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
cites work
Cancer drugs in the United States: Justum Pretium--the just price
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
21 January 2018
The price of innovation: new estimates of drug development costs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
21 January 2018
Drug development costs when financial risk is measured using the Fama-French three-factor model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
21 January 2018
Foreign free riders and the high price of US medicines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
21 January 2018
Do drug prices reflect development time and government investment?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
21 January 2018
Pharmaceutical research and development: what do we get for all that money?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.28321
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.28321
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
PubMed publication ID
24002792
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24002792
retrieved
3 June 2018
reference URL
http://europepmc.org/abstract/MED/24002792
ResearchGate publication ID
256425615
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit